Title |
Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications
|
---|---|
Published in |
Stem Cell Reviews and Reports, September 2016
|
DOI | 10.1007/s12015-016-9680-6 |
Pubmed ID | |
Authors |
Masahito Yoshihara, Yoshihide Hayashizaki, Yasuhiro Murakawa |
Abstract |
Induced pluripotent stem cells (iPSCs) are a type of pluripotent stem cells generated directly from mature cells through the introduction of key transcription factors. iPSCs can be propagated and differentiated into many cell types in the human body, holding enormous potential in the field of regenerative medicine. However, genomic instability of iPSCs has been reported with the advent of high-throughput technologies such as next-generation sequencing. The presence of genetic variations in iPSCs has raised serious safety concerns, hampering the advancement of iPSC-based novel therapies. Here we summarize our current knowledge on genomic instability of iPSCs, with a particular focus on types of genetic variations and their origins. Importantly, it remains elusive whether genetic variations in iPSCs can be an actual risk factor for adverse effects including malignant outgrowth. Furthermore, we discuss novel approaches to generate iPSCs with fewer genetic variations. Lastly, we outline the safety issues and monitoring strategies of iPSCs in clinical settings. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 2 | 33% |
United Kingdom | 1 | 17% |
United States | 1 | 17% |
Unknown | 2 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 83% |
Scientists | 1 | 17% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 367 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 71 | 19% |
Student > Bachelor | 54 | 15% |
Researcher | 49 | 13% |
Student > Master | 42 | 11% |
Student > Doctoral Student | 20 | 5% |
Other | 36 | 10% |
Unknown | 95 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 109 | 30% |
Agricultural and Biological Sciences | 46 | 13% |
Medicine and Dentistry | 36 | 10% |
Neuroscience | 25 | 7% |
Engineering | 16 | 4% |
Other | 31 | 8% |
Unknown | 104 | 28% |